Home / David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

April 17, 2021

Years ago we were happy with a 7.5 A1c for our patients. Over time we have kept lowering the number to 6.0, but we know that euglycemic patients are usually lower than 5.4, so why stop at 6.0? Part of the reason is the increased risk of hypoglycemia in patients …

Read More »

April 13, 2021

In this week’s Diabetes Disaster Averted, we look at a problem that happens all too often. A patient tries to be discreet about dosing their insulin and ends up with a broken bottle. For far too long our patients have tried to hide the use of a syringe to dose …

Read More »

April 10, 2021

A couple of weeks ago our exercise guru, Dr. Sheri Colberg, had a great article on how different types of exercise can either raise or lower or rapidly lower your glucose levels and what your patients could do about it. This week our intern, Aleksandra Kusic, PharmD Candidate, Florida A&M …

Read More »

April 6, 2021

Just as we are closing in on the 100 million vaccinated mark for US citizens, there seems to be a spring surge in the cases. Living in Florida during Spring Break season gives me a unique view of how people from all over the country will not do the bare …

Read More »

April 3, 2021

As we grow older our bodies like to remind us that we are not the youngsters we used to be. Aches and pains become more frequent, and we can’t seem to do all the activities we did in the past. This is often exacerbated if we have diabetes. Our first …

Read More »

March 30, 2021

On Sunday I was cycling near Clearwater about 20 miles from my house, and my wife was riding in St Pete. As she was doing her 20 mile route her glucose began to fall and she had to stop to take some glucose, as her level was at 46 and …

Read More »

March 27, 2021

There is no doubt that the side effect endpoints a pharma company has to evaluate when they bring a new drug to market have increased over the past 15 years. We often mention that if some of the older diabetes medications had to go through the rigorous studies required today, …

Read More »

March 23, 2021

When a relative is diagnosed with diabetes, your first inclination is to throw everything at the disease and then see what works best. That especially is the case if they start insulin on day 1. It started with a long acting insulin, an SGLT-2, and a GLP-1. This worked well …

Read More »

March 20, 2021

It is a “no brainer” that when you deliver insulin or sulfonylureas there is an effect on diabetes care and immediate glucose levels. To all of us it seems obvious that any diversion from prescribed timing of these medications makes a difference. While it is easy to think that way …

Read More »

March 16, 2021

Alexis Dunn, PharmD. Candidate, FAMU College of Pharmacy, has been looking over the many articles online and in diabetes journals concerning exercise. Some tout aerobic, some weight and strength work, and others seem to say that HIIT is the best way to go. She looked at it a different way, …

Read More »